2m 2m 2m 2m 2m 2m 2m
ABEONA THERAP (ABEO)
NASDAQ
$5.79+$0.07 (+1.14%)
Price as of Jun 23, 2026 6:05 PM EDT- $327.7MMarket Cap
- -2.39%1-Year Change
- BiotechnologyIndustry
ABEONA THERAP (ABEO)
$5.79+$0.07 (+1.14%)
ABEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.72 | ||
Change | -$0.03 (-0.52%) | ||
Open | $5.68 | ||
High | $5.87 | ||
Low | $5.67 | ||
Previous Close | $5.75 | ||
Volume | 1,015,428 | ||
30-Day Average Volume | 979,390 | ||
1-Week Change | 1.24% | ||
1-Month Change | 5.15% | ||
1-Year Change | -2.39% | ||
3-Year Change | 15.09% | ||
5-Year Change | -85.88% | ||
Fundamentals | |||
Shares Outstanding | 57.0M | ||
Total Assets | $198.5M | ||
Market Cap | $327.7M | ||
Enterprise Value | $284.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$17.2M | ||
Free Cash Flow | -$20.7M | ||
EBIT | -$16.4M | ||
EBITDA | -$15.7M | ||
Net Working Capital | $151.9M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | 210 | ||
P/B | 2 | ||
P/E | -19 | ||
PEG | 1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 07/05/2022 | ||
Earnings & Revenue